Sesja plakatowa

Podczas piątkowych sesji konferencyjnych e-postery będą na korytarzu i będą dostępne przez cały dzień konferencji. Zostaną one udostępnione na specjalnym monitorze, na którym uczestnicy konferencji będą mogli przeglądać i omawiać prezentacje.

Flow cytometry for ploidy of hydatidiform mole - optimising the protocol		Cathrine Linnea Hegtmann,Student Researcher at Department of Clinical Genetics at Aalborg University Hospital, Denmark *Emma Ronberg Lildholdt, Department of Clinical Genetics at Aalborg University Hospital, Denmark Helle Lund, Department of Pathology at Aalborg University Hospital Louise Serup Christoffersen, Department of Pathology at Aalborg University Hospital Kirsten Gadgaard, Department of Pathology at Aalborg University Hospital Lone Sunde*, Department of Clinical Genetics at Aalborg University Hospital, Denmark
How long do we need to monitor hCG after evacuation of a complete hydatidiform mole?		Leonoor Coopmans, Department of Gynecologic Oncology, Netherlands Cancer Institute, Amsterdam, Noord-Holland, The Netherlands Michael Seckl, Trophoblastic Tumour Screening & Treatment Centre, Imperial College London Xianne Aguiar, Trophoblastic Tumour Screening & Treatment Centre, Imperial College London Naveed Sarwar, Trophoblastic Tumour Screening & Treatment Centre, Imperial College London Chris Coyle, Trophoblastic Tumour Screening & Treatment Centre, Imperial College London Brenna Swift, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Toronto, Toronto, Ontario, Canada
Regression model of serum human chorionic gonadotropin for molar pregnancies in Center for Trophoblastic Disease Prague		Radovan Turyna, Institute for the Care of Mother and Child, Czech Republic Sona Lisova-Stankova, Third Faculty of Medicine, Charles University Matyas Krejci, Third Faculty of Medicine, Charles University Jindrich Mares, Institute for the Care of Mother and Child, Czech Republic Petr Safar, Institute for the Care of Mother and Child, Czech Republic Jaroslav Feyereisl, Institute for the Care of Mother and Child, Czech Republic Ladislav Krofta, Institute for the Care of Mother and Child, Czech Republic
PD-L1 in gestational trophoblastic disease, an antibody evaluation		Yvonne Marije Hoeijmakers, Department of Gynecology & Obstetrics, Radboud University Medical Center Michiel Simons, Department of Pathology, Radboud University Medical Center, Nijmegen the Netherlands Johan Bulten, Department of Pathology, Radboud University Medical Center, Nijmegen the Netherlands Mark Gorris, Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen *Petronella Ottevanger, Department of Medical Oncology, Radboud University Medical Center, Nijmegen Jolanda de Vries,* Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen Fred Sweep, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen
PD-L1 and PD-L2 expression in gestational trophoblastic disease: Does it influence disease outcome?		Yvonne Marije Hoeijmakers, Department of Gynecology & Obstetrics, Radboud University Medical Center Michiel Simons, Department of Pathology, Radboud University Medical Center, Nijmegen the Netherlands Mark Gorris, Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen Petronella Ottevanger, Department of Medical Oncology, Radboud University Medical Center, Nijmegen Jolanda de Vries, Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen Fred Sweep, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen
A review of cases submitted for molecular genotyping by the Scottish Hydatidiform mole Follow-Up service over a 5 year period		Lesley M. McMahon, Hydatidiform Mole Follow-Up Service (HMFUS) Scotland, Ninewells Hospital and Medical School Amy Snaddon, Hydatidiform Mole Follow-Up Service (HMFUS) Scotland, Ninewells Hospital and Medical School Lyndsey Cuthill, Hydatidiform Mole Follow-Up Service (HMFUS) Scotland, Ninewells Hospital and Medical School Leigh Jenkins, Hydatidiform Mole Follow-Up Service (HMFUS) Scotland, Ninewells Hospital and Medical School Elaine Coupar, Hydatidiform Mole Follow-Up Service (HMFUS) Scotland, Ninewells Hospital and Medical School Lesley Christie, Hydatidiform Mole Follow-Up Service (HMFUS) Scotland, Ninewells Hospital and Medical School Karen Gillespie, East of Scotland Regional Genetics (ESRG) Service, Ninewells Hospital and Medical School, Dundee Arlene Alder, East of Scotland Regional Genetics (ESRG) Service, Ninewells Hospital and Medical School, Dundee Gemma Moffat, East of Scotland Regional Genetics (ESRG) Service, Ninewells Hospital and Medical School, Dundee Refaat Youssef, Hydatidiform Mole Follow-Up Service (HMFUS) Scotland, Ninewells Hospital and Medical School
Incidence of persistent trophoblastic disease at tertiary gestational trophoblastic centre in 3414 patients registered over 3-year period and correlation with histological subtypes		Dr. Sojin Park, Charing Cross Hospital, London Dr. Geoff Maher, Charing Cross Hospital, London Ms. Xianne Anguir, Charing Cross Hospital, London Dr. Naveed Sarwar, Charing Cross Hospital, London Prof. M Seckl, Charing Cross Hospital, London Dr. Baljeet Kaur, Charing Cross Hospital, London